echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > my country has achieved full coverage of clinical trials on 5 technical routes for vaccine research and development

    my country has achieved full coverage of clinical trials on 5 technical routes for vaccine research and development

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    China has achieved full coverage of clinical trials on 5 technical routes for new crown vaccine research and development
    China has achieved full coverage of clinical trials on 5 technical routes for new crown vaccine research and development China has achieved full coverage of clinical trials on 5 technical routes for new crown vaccine research and development

    China News Service, September 7th.
    On the 7th, Zheng Zhongwei, the leader of the vaccine research and development team of the scientific research team and director of the Science and Technology Development Center of the National Health Commission, said on the 7th that China’s deployment of new coronavirus vaccines develops all vaccines for 5 technical routes.
    Achieved full coverage of clinical trials
    .

    On the 7th, the State Council's Joint Prevention and Control Mechanism held a press conference on furthering the situation regarding epidemic prevention and control and vaccination
    .


    A reporter asked at the meeting: As early as the beginning of last year, my country has deployed five technical routes for the development of new coronavirus vaccines.


    State Council

    In this regard, Zheng Zhongwei pointed out that China has laid out 5 technical routes from the beginning of the outbreak to promote the research and development of new coronavirus vaccines, including inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines and nucleic acid vaccines.
    , The main purpose is to ensure the success rate
    .

    "Here I can give you a clear message.
    So far, all vaccines of our 5 technical routes have achieved full coverage of clinical trials
    .


    " Zheng Zhongwei said, of which 3 inactivated vaccines have been attached by the State Food and Drug Administration.


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.